Phathom Pharmaceuticals

+$0.26 (+0.78%) Today
$0.00 (0.00%) As of 12:12 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.

About PHAT

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. Its product candidate vonoprazan is an oral small molecule potassium-competitive acid blocker.

CEO
Terrie Curran
Employees
55
Headquarters
Florham Park, New Jersey
Founded
2018

PHAT Key Statistics

Market Cap
1.05B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.33K
High Today
$33.81
Low Today
$32.43
Open Price
$33.20
Volume
131.35K
52 Week High
$50.78
52 Week Low
$29.79

PHAT Earnings

-$3.97
-$2.65
-$1.32
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure